Market Overview:
The global pet medication market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing trend of pet ownership, rising awareness about animal health, and growing demand for premium quality pet medications. The global pet medication market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into antibiotics, antifungal products, flea products, and other products. The antibiotics segment accounted for a major share of the global pet medication market in 2017 and is projected to grow at a CAGR of 6% during the forecast period from 2018 to 2030. This growth can be attributed to an increase in bacterial infections among pets due to changing lifestyles and environmental conditions.
Product Definition:
Pet medication is any drug or other substance that is used to treat an illness, injury, or other medical condition in a pet. The most common types of pet medications are antibiotics, painkillers, and vaccines.
Antibiotics:
Antibiotics Market Size, Share & Trends Analysis Report By Product (Penicillin, Cephalosporin), By Application (Cancer/Inflammation, Infectious Disease), And Segment Forecasts, 2019 - 2026 -> The global antibiotics market size was valued at USD 25.5 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 2.7% from 2019 to 2026.
Antifungal:
Antifungal is a medication used to treat fungal infections. The most common types of fungal infections include athlete's foot, ringworm, and jock itch. Antifungal medications are primarily used in the treatment of skin diseases but can also be used to treat some ear and eye infections as well as certain systemic (body-wide) fungal infections.
Application Insights:
The dog application segment led the global medication market in 2017. The pet dogs across the globe are becoming increasingly susceptible to a variety of diseases and disorders owing to unhealthy lifestyle, improper diet, unhygienic surroundings and lack of physical exercise. This trend is expected to drive demand for various pet medications over the forecast period.
In addition, rising awareness among people about companion animals and their health is anticipated to further propel growth over the coming years. In addition, increasing number of households having pets as a part-time job has also increased spending on vet care services which will boost industry growth further during this period. However due to rising cases of animal abandonment across countries such as India China etc., there has been a decline in adoption rates which will have an adverse impact on industry growth during this period but eventually turn around positive with time passing by.
Regional Analysis:
North America dominated the global pet medication market in 2017. This can be attributed to increasing pet ownership, high expenditure on veterinary care and rising awareness about animal health. According to a study published by the American Pet Products Association (APPA), in 2016, around 68% of U.S households owned at least one dog while 59% owned cats.
In Asia Pacific region, China accounted for the largest revenue share followed by Japan owing to rapid urbanization along with growing disposable income especially among middle-class population groups which includes corporate professionals as well as government employees who have enough time and money for pets but not necessarily a family member or children.
Growth Factors:
- Increasing pet ownership: The global pet population is expected to grow at a CAGR of 3.8% from 2016 to 2020, reaching 862 million by 2020. This growth in the pet population is primarily attributed to the increase in urbanization and rising disposable incomes around the world.
- Rising awareness about animal health and preventive care: There has been a rise in awareness among pet owners about animal health and preventive care in recent years, which has led to an increase in demand for pet medication products.
- Technological advancements: The development of new technologies such as nanotechnology-based products is aiding the growth of the global Pet Medication market by providing innovative solutions for various diseases affecting pets.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pet Medication Market Research Report
By Type
Antibiotics, Antifungal, Flea Products
By Application
Cat, Dog, Horse, Fish, Other
By Companies
Zoetis, Merck, Merial, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, Nexvet, Aratana Therapeutics, Kindred Biosciences, Ambrx, Entest Biomedical, Taconic Biosciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Pet Medication Market Report Segments:
The global Pet Medication market is segmented on the basis of:
Types
Antibiotics, Antifungal, Flea Products
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cat, Dog, Horse, Fish, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zoetis
- Merck
- Merial
- Elanco
- Bayer
- Boehringer
- Novartis
- Virbac
- Ceva
- Vetoquinol
- Nexvet
- Aratana Therapeutics
- Kindred Biosciences
- Ambrx
- Entest Biomedical
- Taconic Biosciences
Highlights of The Pet Medication Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Antifungal
- Flea Products
- By Application:
- Cat
- Dog
- Horse
- Fish
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pet Medication Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pet medication is a term used to describe any type of medication that can be given to a pet. This includes both prescription and over-the-counter medications.
Some of the major companies in the pet medication market are Zoetis, Merck, Merial, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, Nexvet, Aratana Therapeutics, Kindred Biosciences, Ambrx, Entest Biomedical, Taconic Biosciences.
The pet medication market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pet Medication Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pet Medication Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pet Medication Market - Supply Chain
4.5. Global Pet Medication Market Forecast
4.5.1. Pet Medication Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pet Medication Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pet Medication Market Absolute $ Opportunity
5. Global Pet Medication Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pet Medication Market Size and Volume Forecast by Type
5.3.1. Antibiotics
5.3.2. Antifungal
5.3.3. Flea Products
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pet Medication Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pet Medication Market Size and Volume Forecast by Application
6.3.1. Cat
6.3.2. Dog
6.3.3. Horse
6.3.4. Fish
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pet Medication Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pet Medication Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pet Medication Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pet Medication Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pet Medication Demand Share Forecast, 2019-2029
9. North America Pet Medication Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pet Medication Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pet Medication Market Size and Volume Forecast by Application
9.4.1. Cat
9.4.2. Dog
9.4.3. Horse
9.4.4. Fish
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pet Medication Market Size and Volume Forecast by Type
9.7.1. Antibiotics
9.7.2. Antifungal
9.7.3. Flea Products
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pet Medication Demand Share Forecast, 2019-2029
10. Latin America Pet Medication Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pet Medication Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pet Medication Market Size and Volume Forecast by Application
10.4.1. Cat
10.4.2. Dog
10.4.3. Horse
10.4.4. Fish
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pet Medication Market Size and Volume Forecast by Type
10.7.1. Antibiotics
10.7.2. Antifungal
10.7.3. Flea Products
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pet Medication Demand Share Forecast, 2019-2029
11. Europe Pet Medication Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pet Medication Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pet Medication Market Size and Volume Forecast by Application
11.4.1. Cat
11.4.2. Dog
11.4.3. Horse
11.4.4. Fish
11.4.5. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pet Medication Market Size and Volume Forecast by Type
11.7.1. Antibiotics
11.7.2. Antifungal
11.7.3. Flea Products
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pet Medication Demand Share, 2019-2029
12. Asia Pacific Pet Medication Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pet Medication Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pet Medication Market Size and Volume Forecast by Application
12.4.1. Cat
12.4.2. Dog
12.4.3. Horse
12.4.4. Fish
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pet Medication Market Size and Volume Forecast by Type
12.7.1. Antibiotics
12.7.2. Antifungal
12.7.3. Flea Products
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pet Medication Demand Share, 2019-2029
13. Middle East & Africa Pet Medication Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pet Medication Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pet Medication Market Size and Volume Forecast by Application
13.4.1. Cat
13.4.2. Dog
13.4.3. Horse
13.4.4. Fish
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pet Medication Market Size and Volume Forecast by Type
13.7.1. Antibiotics
13.7.2. Antifungal
13.7.3. Flea Products
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pet Medication Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Pet Medication Market: Market Share Analysis
14.2. Pet Medication Distributors and Customers
14.3. Pet Medication Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Zoetis
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merial
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Elanco
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bayer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Boehringer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Novartis
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Virbac
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Ceva
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Vetoquinol
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Nexvet
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Aratana Therapeutics
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Kindred Biosciences
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Ambrx
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Entest Biomedical
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Taconic Biosciences
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
